Skip to main content
Clinical Trials/NCT00994409
NCT00994409CompletedNot Applicable

Berliner Schlaganfallregister - Nachbefragung Von Patienten Mit Schlaganfall

Charite University, Berlin, Germany1 site in 1 country1,200 target enrollmentStarted: July 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
1,200
Locations
1
Primary Endpoint
Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness.

Study Overview

Brief Summary

The objective of this trial is to guarantee a follow-up of all stroke and transient ischemic attack (TIA) patients. With this follow-up assessment long term effects of therapy and prevention measures can be detected and monitored. It is part of quality assurance.

Detailed Description

Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness Key secondary endpoint(s): Compliance/adherence with discharge medication. Re-events. Degree of Disability. Activities of daily living. Mortality.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • all patients eligible

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness.

Time Frame: September 2010

Secondary Outcomes

  • Compliance/adherence with discharge medication Activities of daily living(September 2010)
  • Re-events(September 2010)
  • Degree of Disability(September 2010)
  • Mortality(September 2010)

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials